Experiment 636876
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | WAGNER,J: WAGNER,ML: HENING,WA:. (1998). BEYOND BENZODIAZEPINES: ALTERNATIVE PHARMACOLOGIC AGENTS FOR THE TREATMENT OF INSOMNIA.. 32(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | SUSTAINED-RELEASE MELATONIN 2 MG INCREASED SLEEP EFFICIENCY AND DECREASED TIME AWAKE AFTER SLEEP ONSET IN ELDERLY PEOPLE WITH CHRONIC INSOMNIA, WITHOUT AFFECTING TOTAL SLEEP TIME. THE USE OF SUSTAINED-RELEASE PREPARATIONS THAT MAINTAIN EFFECTIVE SERUM CONCENTRATIONS THROUGHOUT THE NIGHT AND A LONGER DURATION OF TREATMENT (3 WK) MAY HAVE BEEN RESPONSIBLE FOR THESE BENEFICIAL EFFECTS. ALTHOUGH THESE STUDIES APPEAR PROMISING, THE ANALYSIS OF PATIENTS' SLEEP WAS BASED ON ACTIGRAPHIC PARAMETERS, WHICH ARE LESS SENSITIVE THAN POLYSOMNOGRAPHIC MEASUREMENTS. |
| Dose amount | 2.0 MG |
| Number | 9 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |